Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease
Biomolecules · 10.04.2025 · 15 (4) · 557
DOI: 10.3390/biom15040557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.04.2025. Verfasst von So Young Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Feces, Leukocyte L1 Antigen Complex, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yeouido St. Mary's Hospital, Ministry of Science and ICT (MSIT), Republic of Korea, Institute of Clinical Medicine Research at Yeouido St. Mary’s Hospital, Catholic University of Korea.
Abstract (Originalsprache)
Background/Objectives: Fecal calprotectin (FC) is a biomarker of intestinal inflammation widely used in the assessment of gastrointestinal disorders. However, its role in chronic kidney disease (CKD) remains unclear. Given the growing recognition of the gut–kidney axis in CKD pathophysiology, this study aimed to investigate the association between FC levels, systemic inflammation, renal outcomes, and mortality in CKD patients. Methods: We enrolled a total of 515 CKD patients who underwent fecal calprotectin measurement between 2016 and 2023. After applying the exclusion criteria (inflammatory bowel disease, ongoing renal replacement therapy, or incomplete laboratory data), 260 patients were included in the final analysis and stratified into low-FC (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul 06978, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea.
ORCID-Profile: So Young Lee, Kyungdo Han, Hyuk-Sang Kwon, Eun Sil Koh, Sungjin Chung
Förderung
- Yeouido St. Mary's Hospital
- Ministry of Science and ICT (MSIT), Republic of Korea
- Institute of Clinical Medicine Research at Yeouido St. Mary’s Hospital, Catholic University of Korea
Zitieren
APA
Lee, S. Y., Han, K., Kwon, H. S., Koh, E. S., & Chung, S. (2025). Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease. Biomolecules, 15(4), 557. https://doi.org/10.3390/biom15040557
Vancouver
Lee SY, Han K, Kwon HS, Koh ES, Chung S. Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease. Biomolecules. 2025;15(4):557. doi:10.3390/biom15040557
BibTeX
@article{Lee2025,
author = {Lee, So Young and Han, Kyungdo and Kwon, Hyuk-Sang and Koh, Eun Sil and Chung, Sungjin},
title = {Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {4},
pages = {557},
doi = {10.3390/biom15040557}
}
EUVIMED